Operating Lease, Right-of-Use Asset of Keenova Therapeutics plc from 29 Mar 2019 to 27 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Keenova Therapeutics plc quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 29 Mar 2019 to 27 Dec 2024.
  • Keenova Therapeutics plc Operating Lease, Right-of-Use Asset for the quarter ending 27 Dec 2024 was $56,300,000, a 11% increase year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Keenova Therapeutics plc Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $56,300,000 +$5,400,000 +11% 27 Dec 2024 10-K 13 Mar 2025 2024 FY
Q4 2023 $50,900,000 +$12,800,000 +34% 29 Dec 2023 10-K 13 Mar 2025 2024 FY
Q4 2022 $38,100,000 +$3,100,000 +8.9% 30 Dec 2022 10-K 26 Mar 2024 2023 FY
Q4 2021 $35,000,000 -$23,600,000 -40% 31 Dec 2021 10-K 03 Mar 2023 2022 FY
Q4 2020 $58,600,000 -$24,900,000 -30% 25 Dec 2020 10-K 15 Mar 2022 2021 FY
Q4 2019 $83,500,000 27 Dec 2019 10-K 10 Mar 2021 2020 FY
Q3 2019 $84,700,000 27 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $90,600,000 28 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $80,800,000 29 Mar 2019 10-Q 07 May 2019 2019 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.